Letroz 2.5 Tablet is used to treat hormone-sensitive breast cancer in postmenopausal women, including as initial or subsequent treatment in early and advanced disease, and may be used following tamoxifen therapy.
It contains letrozole (2.5 mg), an aromatase inhibitor. Take it as prescribed; do not stop it without specialist advice.
Attend all monitoring appointments, including bone density assessments and cholesterol checks, to support safe long-term treatment alongside this medicine.
Tell your doctor about any osteoporosis, liver problems or history of blood clots before starting, and about all other medicines. Women who may still become pregnant must use effective contraception, as letrozole is teratogenic. Report any unusual bone pain, visual changes or symptoms of depression.


















































































